Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
David Weisman, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Uncovering TK2d: How to Navigate Diagnostic Challenges
A Closer Look at the Biology Behind MS Progression
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Navigating Emerging Treatment Options in MG
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Navigating Emerging Biomarkers in MS Care
Exploring Genetic Links Between EBV Clearance and MS Risk
More Than a Myopathy: The Lived Experience of TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.